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SUMMARY
The most frequent chronic respiratory problems in childhood are 
asthma and cystic fibrosis (CF). The purpose of this paper is to review 
basic knowledge and recent advances in oral health and associated dental 
morbidities in children with asthma and CF. This review considered clinical 
trials and systematic reviews related to oral health in children with CRD. An 
online base Medline was searched to determine relevant papers, using the 
combination of the following terms: “asthma”, “cystic fibrosis”, “caries”, 
“dental erosion”, and “oral health”. Oral health problems in children with 
chronic respiratory diseases (CRD) may be influenced by natural course 
of the disease, pharmacotherapy (inhalation therapy with bronchodilators 
and inhaled corticosteroids in asthmatic patients, systemic antibiotics 
and pancreatic enzyme replacement therapy in CF patients), medication 
administration technique and nutritional habits. Children with CRD may 
have higher prevalence of oral diseases. Patients and their parents, but also 
general paediatricians and pulmonologists, should be aware of importance 
of good oral health. Dental practitioners should be more informed about risk 
factors and specificities of oral health in these patients. Preventive measures, 
early diagnosis and effective treatment strategies in children with CRD can 
reduce occurrence of oral diseases and improve patient’s quality of life.
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 Introduction
Acute and chronic respiratory diseases (CRD) are the 
most frequent medical problems in childhood. Prevalence 
of CRD is increasing worldwide, why dental practitioners 
should be more aware of the specificities of oral health in 
these patients. Specificities of particular clinical problems 
in patients with CRD come from natural course of the 
disease, pharmacotherapy and nutritional risk factors that 
have not favourable impact on the appearance of oral 
diseases. Risk factors associated with oral diseases in 
children are presented in Table 1. 
The purpose of this paper is to review basic 
knowledge and recent advances in oral health and 
associated dental morbidities in two most common 
chronic respiratory diseases in childhood - asthma and 
cystic fibrosis (CF).
Table 1. Risk factors for oral diseases in children
Dental caries Gingivitis Dental erosion
• Frequent use 
of fermentable 
carbohydrates 
• Decreased 
salivary flow 
and pH 
• Increased counts 
of Streptococcus 
mutans and 
Lactobacilli
• Dehydratation of 
oral mucosa due to 
the mouthbreathing 
• Decreased 
salivary flow and 
subsequent reduced 
concentration of 
secretory IgA 
• Alteration of 
immune response
• Frequent exposure 
of teeth to extrinsic 
and intrinsic acids 
• Decreased salivary 
flow and pH
Material and Methods
This review considered clinical trials and systematic 
reviews related to oral health in children with CRD. An 
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It was speculated that mouth breathing and higher intake 
of sweet drinks, which are commonly used in an attempt 
to eliminate the bad taste of the inhaled medication or 
to reduce the desiccating effect of mouth breathing and 
reduced salivary flow, may be related to worse oral health 
in primary dentition7,8. On the other hand, several studies 
with comparable methodology showed no relationship 
between asthma and caries incidence, regardless the age 
of the participants10-16.
It has been reported that asthmatics are in a higher 
risk to develop dental erosions17,18. This was explained 
by negative influence of frequent consumption of acidic 
soft drinks, acidity of some nebulised solutions (pH<5.5), 
and possible presence of gastroesophageal reflux disease, 
which show the erosive effect. On the other hand, 
Dugmore and Rock19 showed no differences in prevalence 
of dental erosions between asthmatic and healthy children.
Respiratory disorders may also be associated with 
enamel developmental defects. Guergolette et al.20 
reported higher prevalence of enamel defects in asthmatic 
than in healthy children with demarcated diffused 
opacities being the most prevalent. Since ameloblasts are 
highly sensitive to the lack of oxygen, authors assumed 
that enamel defects are attributable to the episodes of 
hypoxemia during amelogenesis. 
Chronic therapy with ICS, oral dryness due to mouth 
breathing, and proinflammatory cytokine release in 
persistent asthma have been related to greater incidence 
of gingivitis in asthmatic patients9,21,22. Children with 
allergic asthma phenotype frequently have associated 
allergic rhinitis, manifested with various degree of nasal 
obstruction. Partial nasal obstruction and reduced nasal 
clearance may cause pronounced mouth breathing with 
reduced salivary flow. This leads to subsequent bigger 
accumulation of dental plaque23. McDeera et al.22 showed 
raised prevalence of dental calculus in asthmatic children 
which can be contributed to the increased concentrations 
of salivary calcium and phosphate ions24.
Asthmatic children, especially those with associated 
allergic rhinitis, may have facial dysmorhism with 
increased facial height, higher palatal vaults, overjets 
and posterior crossbites25,26.  It is probably caused by 
difficulty breathing, preferable mouth breathing due to 
nasal obstruction and diminished respiratory reserve in 
those patients with severe airway obstruction.
From the above, it is clear that attitudes about the 
oral health of children with asthma are not consistent. 
Some epidemiological and clinical studies showed 
no relationship between asthma and oral diseases, 
while other studies demonstrated an increased risk for 
oral diseases in asthmatic patients. However, authors 
suggesting increased incidence of caries, gingivitis, 
candidiasis, tooth erosion, changes in the salivary 
flow and composition, etc. emphasized difficulties in 
finding the exact reason for higher prevalence of oral 
diseases in children with asthma27-29. One of the possible 
online base Medline was searched to determine relevant 
papers, using the combination of the following terms: 
“asthma”, “cystic fibrosis”, “caries”, “dental erosion”, and 
“oral health”. The last search date was March 31st 2017.
Asthma
Asthma is a chronic inflammatory disease, 
characterised by episodes of cough, wheezing, chest 
tightness and difficult breathing. Its prevalence in 
childhood is increasing worldwide, causing hospital 
admissions, school and work absenteeism, decreased 
quality of life and even asthma-related death. Latest 
Global initiative for asthma (GINA) estimated that the 
number of people with asthma in the world may be as 
high as 334 million. Although prevalence of asthma 
varies widely between the countries, it is estimated that 
about 14% of the world’s children were likely to have had 
asthmatic symptoms1. Besides GINA, numerous national 
asthma-reduction plans established useful diagnostic 
criteria and different treatment modalities which resulted 
in proper diagnosis and decrease of asthma exacerbations.
The cornerstones of modern therapy are inhaled 
bronchodilators (mostly β2 agonists) and anti-
inflammatory drugs (inhaled corticosteroids (ICS). 
Systemic adverse effects such as decreased growth 
velocity, adrenal suppression or osteoporosis are not 
related with chronic use of low and moderate doses of 
ICS. Local adverse effects- mostly dysphonia and oral 
diseases are associated with frequent use of inhaled 
bronchodilators or chronic use of ICS. Proper techniques 
of inhalation, use of spacers with metered-dose inhalers 
(MDI) and good oral hygiene may decrease the incidence 
of these complications. Most of the children with asthma 
have a mild disease treated intermittently with inhaled 
β2 agonists. Excessive and/or prolonged use of either 
nebulised or β2 agonists from MDI can lead to a reduced 
salivary flow which is essential for oral health. Alteration 
of protective role of saliva leads to increased number 
of cariogenic microorganisms2-4. A dry powder inhaler 
(DPI) is a device that delivers asthma medication in 
size of respirable particle (from 1-5μm in diameter) in 
mixture with excipients which carries the active drug. 
Most commonly used carrier is carbohydrate - lactose 
monohydrate. During inhalation from DPI, drug particles 
separate from the carrier and carried into small airways in 
the lungs. Larger, lactose particles, are deposited on the 
oropharyngeal mucosa which can contribute to elevated 
caries risk5.
It has been suggested that asthmatic patients may 
have a higher risk for oral diseases, either as a result of 
the medical condition or as adverse effects of medication. 
A higher prevalence of caries in school children6 and 
adolescents7-9 with asthma compared with healthy 
children has been reported. Ersin et al.6 demonstrated 
that the duration of therapy and seriousness of the disease 
had significant influence on the caries risk in asthmatics. 
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initial bacterial infection or chronic colonization of lower 
airways in infancy and childhood (mostly Staphylococcus 
aureus), consists of chronic use of β-lactam antibiotics. 
It may also reduce cariogenic flora, i.e. Streptococcus 
mutans which is susceptible to β-lactams33,39,40, and 
decreases plaque pathogenicity32. Over the ages, 
predominant pathogen in CF lungs becomes Pseudomonas 
aeruginosa. Usual therapies are chronic treatments with 
inhaled tobramycin or colomycin, which are not effective 
against Streptococcus mutans. Therefore, adolescents and 
adults may lose protection against caries40.
Increased salivary pH and higher concentration 
of calcium in saliva may result in increased calculus 
formation37. The prevalence of dental calculus formation 
was not found to be significantly different between 
children with CF and other chronic respiratory diseases43. 
Children with CF may have dental maturation delay 
and higher risk for development of systemic enamel 
defects44. It was speculated that this was probably caused 
by metabolic and nutritional disorders and frequent 
use of antibiotics, which can have influence on teeth 
development42. Ferrazzano et al.42 found enamel defects 
in 55.6% of CF patients, while they were present in 22.7% 
of healthy persons. In addition, more severe enamel 
defects with hypoplasia and partial loss of enamel had 
been noted in the CF group. Azevedo et al.45 showed no 
difference in occurrence of lesions on deciduous teeth, but 
enamel defects on permanent teeth were more prevalent in 
CF children than in healthy controls. High prevalence of 
tetracycline discolorations associated with frequent use of 
these drugs in the past35,36 is not common nowadays.
One of less frequent indicators of current malpractice 
in CF treatment is an inadequate administration of PERT, 
which happen because of improper use of product that is 
commercially available. Exocrine pancreatic insufficiency 
is clinically manifested by symptoms of maldigestion 
(greasy stools, flatulation, abdominal pain, rectal 
prolapses) when residual pancreatic function is <10%. 
Mainly of porcine origin, enteric-coated microsphere 
preparations were designed to avoid inactivation by acidic 
environment in the stomach. It dissolves in the duodenum 
when pH becomes alkaline. In case of crushing or 
chewing of microspheres in the mouth, severe oral lesions 
may appear and, in addition, symptoms of maldigestion 
persist. Irritation of the oral mucosa may be avoided by 
swallowing and not chewing the medications, or mixing 
them in foods46.
Conclusions
Children with CRD may have higher prevalence of 
oral diseases influenced by numerous contributing factors 
in compare to healthy peers. Dental practitioners should 
be more informed about risk factors and specificities of 
explanations for the differences between the studies may 
be the nonhomogeneity of the samples, i.e. severity of the 
disease and specificity of the inhalation drugs used by the 
subjects in diverse studies.
Cystic Fibrosis
CF is the most common autosomal-recessive disease 
in Caucasians, with an incidence of 1:1.700-1:40.000 
newborns. It is caused by a mutation in a gene located in 
the long arm of chromosome 7, coding for the complex 
protein called cystic fibrosis transmembrane regulator 
(CFTR). The main function of CFTR is transepithelial 
chloride transport. In case of nonfunctional ion membrane 
transport, secretions in the exocrine glands (including 
salivary glands) become thick and dehydrated. This results 
in systemic illness with dominant obstructive, suppurative 
lung disease that leads to diffuse bronchiectasis and 
chronic respiratory insufficiency as a main cause 
of dead. In most of the cases, CF patients also have 
maldigestion due to exocrine pancreatic insufficiency that 
leads to malnutrition which correlates to unfavourable 
outcome. In the last decades, there have been numerous 
improvements in early diagnosis and different treatment 
modalities, including lung transplant, with increased life 
expectancy and quality of life in patients with CF30,31. 
Therapy consists of high-calorie diet, pancreatic enzyme 
replacement therapy (PERT), fat soluble vitamins 
supplementation and medications that lead to increased 
mucus clearance (bronchodilators, mucolytics). In 
addition, patients are treated with inhaled and systemic 
antibiotic therapy in order to control chronic bacterial 
colonization in lower airways or treat exacerbation of 
suppurative lung disease.
Children and adolescents with CF are thought to be 
at an increased risk for oral diseases. This was thought to 
be related to the high calorie diet with frequent in-between 
sugar-rich meals, which may contribute to the high caries 
risk32,33. In order to preserve lung function and increase 
mucociliary clearance, inchalatory bronchodilators 
are used regularly, which may reduce salivary flow34. 
However, the results of numerous studies showed that 
children with CF have significantly lower incidence 
of caries35-40 and better gingival health32,41,42 when 
compared to healthy peers. It has also been shown that 
the incidence of dental caries in the primary dentition was 
lower in children with CF in comparison with children 
with other chronic respiratory diseases43. One of the 
explanations could be that CF patients probably maintain 
better oral hygiene to prevent spread of oral infections 
into the lungs33, but better oral hygiene habits were not 
confirmed32,40. It has also been suggested that CF patients 
have significantly higher salivary pH and buffering 
capacity37 which may act as a compensatory mechanism 
and contribute to the lower caries profile. It is most likely 
that the chronic use of antibiotics reduces the incidence of 
caries in children with CF. Early eradication strategies of 
Balk J Dent Med, Vol 23, 2019 Oral Health and Respiratory Diseases  13
11. Meldrum AM, Thomson WM, Drummond BK, Sears MR. 
Is asthma a risk factor for dental caries? Finding from a 
cohort study. Caries Res, 2001;35:235-239.
12. Shulman JD, Taylor SE, Nunn ME. The association between 
asthma and dental caries in children and adolescents: 
a population-based case-control study. Caries Res, 
2001;35:240-246. 
13. Shulman JD, Nunn ME, Taylor SE, Rivera-Hidalgo F. The 
prevalence of periodontal-related changes in adolescents 
with asthma: results of the Third Annual National Health 
and Nutrition Examinations Survey. Pediatr Dent, 
2003;25:279-284.
14. Ferrazzano GF, Sangianantoni G, Cantile T, Amato I, Ingenito 
A, Noschese P. Dental health in asthmatic children: a South 
Italy study. J Dent Child, 2012;79:170-175.
15. Ehsani S, Moin M, Meighani G, Pourhashemi SJ, 
Khayatpisheh H, Yarahmadi N. Oral health status in 
preschool asthmatic children in Iran. J Allergy Asthma 
Immunol, 2013;12:254-261.
16. Markovic D, Peric T, Sovtic A, Minic P. Oral health in 
children with asthma. Srp Arh Celok Lek, 2015;143:539-544.
17. Sivasithamparam K, Young WG, Jirattanasopa V, Priest 
J, Khan F, Harbrow D et al. Dental erosion in asthma: A 
case-control study from south east Queensland. Austr Dent 
J, 2002;47:298-303.
18. Al-Dlaigan YH, Shaw L, Smith AJ. Is there a relationship 
between asthma and dental erosion? A case control study. Int 
J Paediatr Dent, 2002;12:189-200.
19. Dugmore CR, Rock WP. Asthma and tooth erosion. Is there 
an association? Int J Paediatr Dent, 2003;13:417-424.
20. Guergolette RP, Dezan CC, Frossard WTG, Ferreira 
FB, Cerci Neto A, Fernandes KB. Prevalence of 
developmental defects of enamel in children and adolescents 
with asthma. J Bras Pneumol, 2009;35:295-300.
21. Steinbacher DM, Glick M. The dental patient with asthma: 
an update and oral health considerations. J Am Dent Assoc, 
2001;132:1229-1239.
22. McDerra EJ, Pollard MA, Curzon ME. The dental status 
of asthmatic British school children. Pediatr Dent, 
1998;20:275-283.
23. Dykewicz M. Rhinitis and sinusitis. J Allergy Clin Immun, 
2003;111:S520-529.
24. Wotman S, Mercadante J, Mandel ID, Goldman RS, 
Denning C. The occurrence of calculus in normal children, 
children with cystic fibrosis, and children with asthma. J 
Periodontol, 1973;44:278-280.
25. Bresolin D, Shapiro PA, Shapiro GG, Chapko MK, Dassel 
S. Mouth breathing in allergic children: its relationship to 
dentofacial development. Am J Orthod, 1983;83:334-340.
26. Venetikidou A. Incidence of malocclusion in asthmatic 
children. J Clin Pediatr Dent, 1993;17:89-94.
27. Ellepola AN, Samaranayake LP. Inhalational and topical 
steroids, and oral candidiosis: a mini review. Oral Dis, 
2001;7:211-216.
28. Kargul B, Tanboga I, Ergeneli S, Karakoc F, Dagli E. 
Inhaler medicament effects on saliva and plaque pH in 
asthmatic children. J Clin Pediatr Dent, 1998;22:137-140.
29. Shaw L, Al-Dlaigan YH, Smith A. Childhood asthma and 
dental erosion. J Dent Child, 2000;67:102-106.
30. O’Sullivan B, Freedman S.  Cystic fibrosis. Lancet, 
2009;373:1891-1904.
oral health in these patients. Patients and their parents 
should be educated about importance of oral health and 
possible severe general health consequences in case of 
presence of oral diseases or its complications. It seems 
that the occurrence of oral changes could be influenced by 
improper use of inhalation and PER therapy. Therefore, 
it is important to educate children and their parents 
on the proper use of these medicines. Although strict 
clinical protocols for the prevention of oral diseases in 
patients with CRD have not been defined so far, it would 
be of great importance if general paediatricians and 
pulmonologists would be aware of importance of good 
oral health suggesting regular dental examinations every 
three months. Preventive measures, early diagnosis and 
effective treatment strategies can reduce occurrence of 
oral diseases and make their complications less frequent 
which all may have significant impact on possible 
co-morbidities and patient’s quality of life. 
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